D21 IMMUNE PATHWAYS IN ACUTE LUNG INJURY AND FIBROSIS: Novel Non-Catalytic Substrate-Selective P38α-Specific Mapk Inhibitors With Endothelial-Stabilizing And Anti-Inflammatory Activity That Mitigates Experimental Acute Lung Injury
Background: p38 MAPK signaling is important in regulating lung inflammation and injury, but the currently available p38 catalytic inhibitors (e.g. SB203580), which target the kinase active site, were poorly effective and caused toxicity in clinical trials. Methods: We used CADD to search a 60,000 co...
Gespeichert in:
Veröffentlicht in: | American journal of respiratory and critical care medicine 2017-01, Vol.195 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!